Release Date: 27/04/23 12:27 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 847.49KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%